SummitTX Capital »

Taysha Gene Therapies shares owned by SummitTX Capital

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $311k 57k 5.50

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Asml Holding N V N Y Registry Shs (ASML)
Eli Lilly & Co. (LLY)
MKS Instruments (MKSI)
Wal-Mart Stores (WMT)
Paypal Holdings (PYPL)
Applied Materials (AMAT)
Amazon (AMZN)
Anthem (ELV)
Costco Wholesale Corporation (COST)
UnitedHealth (UNH)
Meritage Homes Corporation (MTH)

View all positions for SummitTX Capital

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies